
Protein by which common skin bacteria trigger eczema identified
A decade-long study has identified the factor produced by a common species of skin bacteria that triggers eczema.
Read moreA decade-long study has identified the factor produced by a common species of skin bacteria that triggers eczema.
Read moreMore than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.
Read moreA patient at the Royal Manchester Children’s Hospital (RMCH) was the first in the UK to receive a convalescent plasma transfusion, after being selected through the RECOVERY COVID-19 research study.
Read moreEarly results for a potentially revolutionary brain disease therapy given under compassionate use to a two-year-old has shown promise
Read moreOur first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
Read moreStaff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research
Read moreThe first child in the UK has participated in an international research trial taking place at Royal Manchester Children’s Hospital.
Read moreAs part of the NIHR Your Path in Research campaign, we are shining a spotlight on Emma Charnock, a Senior Paediatric Oncology Research Nurse at Royal Manchester Children’s Hospital.
Read more